Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
50M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
12.3M
-
Shares change
-
+5.04M
-
Total reported value, excl. options
-
$271M
-
Value change
-
+$111M
-
Number of buys
-
32
-
Number of sells
-
-11
-
Price
-
$22.11
Significant Holders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) as of Q3 2018
49 filings reported holding KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share as of Q3 2018.
KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.3M shares
of 50M outstanding shares and own 24.64% of the company stock.
Largest 10 shareholders include SV Health Investors, LLC (2.58M shares), RA CAPITAL MANAGEMENT, LLC (1.44M shares), Vivo Capital, LLC (1.36M shares), VHCP Management III, LLC (1.28M shares), EVENTIDE ASSET MANAGEMENT, LLC (900K shares), VHCP Management II, LLC (759K shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (650K shares), BVF INC/IL (609K shares), INTERWEST VENTURE MANAGEMENT CO (389K shares), and ADAGE CAPITAL PARTNERS GP, L.L.C. (305K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.